Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiang-Li Ning

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Bioorganic & Medicinal Chemistry Letters|March 21, 2021
Discovery of 3-aryl substituted benzoxaboroles as broad-spectrum inhibitors of serine- and metallo-β-lactamasesYu-Hang Yan, Zhao-Feng Li, Xiang-Li Ning, et al.
Nature Communications|March 6, 2025
Knowledge-guided diffusion model for 3D ligand-pharmacophore mappingJun-Lin Yu, Cong Zhou, Xiang-Li Ning, et al.
Bioorganic Chemistry|March 30, 2023
New ε-N-thioglutaryl-lysine derivatives as SIRT5 inhibitors: Chemical synthesis, kinetic and crystallographic studiesJi Deng, Ze-Min Liu, Kai-Rong Zhu, et al.
ACS Medicinal Chemistry Letters|March 18, 2026
Structural Optimization of Benzyl-5-methyl‑1<i>H</i>‑Imidazole Derivatives as Human Glutaminyl Cyclase InhibitorsYu-Ting Chen, Fan-Bo Meng, Yu-Qing Zhuang, et al.
Journal of Chemical Information and Modeling|May 14, 2025
Deciphering Glutaminyl Cyclase Catalytic Pathways Enables Recognition of Anchor Pharmacophores for Inhibitor DiscoveryJing-Wei Wu, Xiang-Li Ning, Biao-Dan Tang, et al.
Bioinformatics (Oxford, England)|September 11, 2019
MeLAD: an integrated resource for metalloenzyme-ligand associationsGen Li, Yu Su, Yu-Hang Yan, et al.
Journal of Medicinal Chemistry|May 31, 2024
X-ray Structure-Guided Discovery of a Potent Benzimidazole Glutaminyl Cyclase Inhibitor That Shows Activity in a Parkinson's Disease Mouse ModelJun Mou, Xiang-Li Ning, Xin-Yue Wang, et al.
Journal of Medicinal Chemistry|June 10, 2021
X-ray Structure-Guided Discovery of a Potent, Orally Bioavailable, Dual Human Indoleamine/Tryptophan 2,3-Dioxygenase (hIDO/hTDO) Inhibitor That Shows Activity in a Mouse Model of Parkinson's DiseaseXiang-Li Ning, Yu-Zhi Li, Cui Huo, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Bioorganic & Medicinal Chemistry Letters|March 21, 2021
Discovery of 3-aryl substituted benzoxaboroles as broad-spectrum inhibitors of serine- and metallo-β-lactamasesYu-Hang Yan, Zhao-Feng Li, Xiang-Li Ning, et al.
Nature Communications|March 6, 2025
Knowledge-guided diffusion model for 3D ligand-pharmacophore mappingJun-Lin Yu, Cong Zhou, Xiang-Li Ning, et al.
Bioorganic Chemistry|March 30, 2023
New ε-N-thioglutaryl-lysine derivatives as SIRT5 inhibitors: Chemical synthesis, kinetic and crystallographic studiesJi Deng, Ze-Min Liu, Kai-Rong Zhu, et al.
ACS Medicinal Chemistry Letters|March 18, 2026
Structural Optimization of Benzyl-5-methyl‑1<i>H</i>‑Imidazole Derivatives as Human Glutaminyl Cyclase InhibitorsYu-Ting Chen, Fan-Bo Meng, Yu-Qing Zhuang, et al.
Journal of Chemical Information and Modeling|May 14, 2025
Deciphering Glutaminyl Cyclase Catalytic Pathways Enables Recognition of Anchor Pharmacophores for Inhibitor DiscoveryJing-Wei Wu, Xiang-Li Ning, Biao-Dan Tang, et al.
Bioinformatics (Oxford, England)|September 11, 2019
MeLAD: an integrated resource for metalloenzyme-ligand associationsGen Li, Yu Su, Yu-Hang Yan, et al.
Journal of Medicinal Chemistry|May 31, 2024
X-ray Structure-Guided Discovery of a Potent Benzimidazole Glutaminyl Cyclase Inhibitor That Shows Activity in a Parkinson's Disease Mouse ModelJun Mou, Xiang-Li Ning, Xin-Yue Wang, et al.
Journal of Medicinal Chemistry|June 10, 2021
X-ray Structure-Guided Discovery of a Potent, Orally Bioavailable, Dual Human Indoleamine/Tryptophan 2,3-Dioxygenase (hIDO/hTDO) Inhibitor That Shows Activity in a Mouse Model of Parkinson's DiseaseXiang-Li Ning, Yu-Zhi Li, Cui Huo, et al.
Pageof 1